Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Cyclin E dependent kinase activity in human breast cancer in relation to cyclin E, p27 and p21 expression and retinoblastoma protein phosphorylation

Oncogene volume 18, pages 2557–2566 (1999)Cite this article

Abstract

The cell cycle machinery is regulated by cyclin dependent kinases and sets of activating and inhibitory proteins. The G1-S control mechanism is often deregulated in tumours supposedly leading to increased kinase activity, phosphorylation of substrates and subsequent S phase entrance. Increased kinase activity has been proposed to be essential in cell cycle aberrations, but few studies have actually shown enhanced kinase activity related to specific cell cycle defects in primary tumours. In the present study we have determined the cyclin E dependent kinase activity (cyclin Ekinase) in 59 primary breast cancers, using an H1-kinase assay, and related the activity to the expression of cyclin E, p27 and p21. In a subgroup of 48 tumours, we further characterized the association between cyclin Ekinase, in vivo phosphorylation of the retinoblastoma protein (pRb) and proliferation. The cyclin Ekinase correlated significantly with cyclin E content and inversely with p27 and p21 expression. P27, but not p21, was associated with low cyclin Ekinase in specimens with normal/low levels of cyclin E. At elevated cyclin E levels, suppression of cyclin Ekinase seemed to require high levels of both p21 and p27. The cyclin Ekinase correlated with the phosphorylation status of pRb as well as with proliferation. Surprisingly, pRb phosphorylation did not correlate with proliferation. Our results support that pRb is a substrate for cyclin Ekinase in primary breast cancer and that deregulation of cyclin E and p27 act through increased CDK-kinase activity, but cyclin E associated events beside pRb phosphorylation might be rate-limiting for entrance into S phase.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 5
Figure 3
Figure 4
Figure 6
Figure 7

Similar content being viewed by others

References

  • Bartek J, Bartkova J and Lukas J. . (1997) Exp. Cell. Res. 237: 1–6.

  • Bukholm IK, Nesland JM, Kåresen R, Jacobsen U and Börresen AL. . 1997 J. Pathol. 181: 140–145.

    Article  CAS  Google Scholar 

  • Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, Shaw P, Yeger H, Morava-Protzner I, Kapusta L, Franssen E, Pritchard KI and Slingerland JM. . 1997 Nat. Med. 3: 227–230.

  • Coats S, Flanagan WM, Nourse J and Roberts JM. . 1996 Science 272: 877–880.

    Article  CAS  Google Scholar 

  • Deng C, Zhang P, Harper JW, Elledge SJ and Leder P. . 1995 Cell 82: 675–684.

    Article  CAS  Google Scholar 

  • Draetta GF. . 1994 Curr. Opin. Cell. Biol. 6: 842–846.

  • Dulic V, Lees E and Reed SI. . 1992 Science 257: 1958–1961.

    Article  CAS  Google Scholar 

  • Ellis PA, Lonning PE, Borresen-Dale A, Aas T, Geisler S, Akslen LA, Salter I, Smith IE and Dowsett M. . 1997 Br. J. Cancer 76: 480–485.

  • Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM, Kaushansky K and Roberts JM. . 1996 Cell 85: 733–744.

    Article  CAS  Google Scholar 

  • Ferrando AA, Balbin M, Pendas AM, Vizoso F, Velasco G and Lopez-Otin C. . 1996 Hum. Genet. 97: 91–94.

  • Fredersdorf S, Burns J, Milne AM, Packman G, Fallis L, Gillett C, Royds JA, Peston D, Hall PA, Hanby AM, Barnes DM, Shousha S, O'Hare MJ and Lu X. . 1997 Proc. Natl. Acad. Sci. USA 97: 6380–6385.

  • Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai L, Zhang P, Dobrowolski S, Bai C, Connel-Crowley L, Swindell E, Fox MP and Wei N. . 1995 Mol. Biol. Cell. 6: 387–400.

  • Hatakeyama M, Brill JA, Fink GR and Weinberg RA. . 1994 Genes Dev. 8: 1759–1771.

  • Hengst L and Reed SI. . 1996 Science 271: 1861–1864.

    Article  CAS  Google Scholar 

  • Hinds P, Mittnacht S, Dulic V, Arnold A, Reed SI and Weinberg RA. . 1992 Cell 70: 993–1006.

    Article  CAS  Google Scholar 

  • Hunter T and Pines J. . 1994 Cell 79: 573–582.

    Article  CAS  Google Scholar 

  • Jiang M, Shao ZM, Wu J, Lu JS, Yu LM, Yuan JD, Han XQ, Shen ZZ and Fontana JA. . 1997 Int. J. Cancer 74: 529–534.

    Article  CAS  Google Scholar 

  • Keyomarski K, Conte Jr D, Toyofuku W and Fox MP. . 1995 Oncogene 11: 941–950.

  • Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanan D, Hayday AC, Frohman LA and Koff A. . 1996 Cell 85: 721–732.

    Article  CAS  Google Scholar 

  • Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgam DO, Franza BR and Roberts JM. . 1992 Science 257: 1689–1694.

    Article  CAS  Google Scholar 

  • Landberg G and Roos G. . 1997 APMIS 105: 575–589.

    Article  CAS  Google Scholar 

  • Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM and Pagano M. . 1997 Nat. Med. 3: 231–234.

  • Lukas J, Aagaard L, Strauss M and Bartek J. . 1995 Cancer Res. 55: 4818–4823.

  • Lukas J, Groshen S, Saffari B, Niu N, Reles A, Wen WH, Felix J, Jones LA, Hall FL and Press MF. . 1997 Am. J. Pathol. 150: 167–175.

  • Lukas J, Herzinger T, Hansen K, Moroni MC, Resnitzky D, Helin K, Reed SI and Bartek J. . 1997 Genes Dev. 11: 1492–1497.

  • Lundberg AS and Weinberg RA. . 1998 Mol. Cell. Biol. 18: 753–761.

    Article  CAS  Google Scholar 

  • Mousses S, Ozcelik H, Lee PD, Malkin D, Bull SB and Andrulis IL. . 1995 Hum. Mol. Genet. 4: 1089–1092.

  • Nevins JR, Leone G, DeGregori J and Jakoi L. . 1997 J. Cell. Phys. 173: 233–236.

  • Nielsen NH, Arnelöv C, Emdin SO and Landberg G. . 1996 Br. J. Cancer 74: 874–880.

  • Nielsen NH, Emdin SO, Cajander J and Landberg G. . 1997 Oncogene 14: 295–304.

    Article  CAS  Google Scholar 

  • Nielsen NH, Lodén M, Cajander J, Emdin SO and Landberg G. . 1999 Breast Cancer Res. Treat. in press.

  • Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, Lee MH, Massague J, Crabtree GR and Roberts JM. . 1994 Nature 372: 570–573.

    Article  CAS  Google Scholar 

  • Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM and Pagano M. . 1995 Mol. Cell. Biol. 15: 2612–2624.

    Article  CAS  Google Scholar 

  • Pagano M, Tam SV, Theodoras AM, Beer-Romero P, Del-Sal G, Chau V, Yew PR, Draetta GF and Rolfe M. . 1995 Science 269: 682–685.

    Article  CAS  Google Scholar 

  • Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR and Roberts JM. . 1997 Nat. Med. 3: 222–225.

  • Resnitzky D and Reed SI. . 1995 Mol. Cell. Biol. 15: 3463–3469.

    Article  CAS  Google Scholar 

  • Sgamboto A, Han EK, Zhou P, Schieren I and Weinstein IB. . 1996 Cancer Res. 56: 1389–1399.

  • Sgamboto A, Doki Y, Schieren I and Weinstein IB. . 1997 Cell Growth Diff. 8: 393–405.

  • Sherr CJ. . 1996 Science 274: 1672–1677.

    Article  CAS  Google Scholar 

  • Sherr CJ and Roberts JM. . 1995 Genes Dev. 9: 1149–1163.

  • Spataro V, Norbury C and Harris AL. . 1998 Br. J. Cancer 77: 448–455.

  • Tan P, Cady B, Wanner M, Worland P, Cukor B, Magi-Galluzzi C, Lavin P, Draetta G, Pagano M and Loda M. . 1997 Cancer Res. 57: 1259–1263.

  • Wakazugi E, Kobayashi T, Takami Y, Ito Y, Miyashiro I, Komoike Y, Takeda T, Shin E, Tataksuka Y, Kikkawa N, Monden T and Monden M. . 1997 Anatom. Pathol. 107: 684–691.

  • Weinberg RA. . 1995 Cell 81: 323–330.

    Article  CAS  Google Scholar 

  • Yasui W, Kuniyasu H, Yokozaki H, Semba S, Shimamoto F and Tahara E. . 1996 Virchows Arch 429: 13–19.

  • Zarkowska T and Mittnacht S. . 1997 J. Biol. Chem. 272: 12738–12746.

    Article  CAS  Google Scholar 

  • Zhang H, Hannon J and Beach D. . 1994 Genes Dev. 8: 1750–1758.

  • Zhao J, Dynlacht B, Imai T, Hori T and Harlow E. . 1998 Genes Dev. 12: 456–461.

Download references

Acknowledgements

We would like to thank Bodil Bäcklund and Britta Lindgren for skilful technical assistance, Björn Tavelin for assistance with statistical questions and Jenny Cajander for the evaluation of Ki-67. This work was supported by grants from the Swedish Cancer Society (3813-B96-01XAB) and Lion's Cancer research foundation, Umeå University.

Author information

Authors and Affiliations

  1. Department of Pathology, Umeå University, Umeå, S-901 87, Sweden

    Martin Lodén, Niels Hilmer Nielsen, Göran Roos & Göran Landberg

  2. Department of Oncology, Umeå University, Umeå, S-901 87, Sweden

    Niels Hilmer Nielsen

  3. Department of Surgery, Umeå University, Umeå, S-901 87, Sweden

    Stefan O Emdin

Authors
  1. Martin Lodén
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Niels Hilmer Nielsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Göran Roos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stefan O Emdin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Göran Landberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lodén, M., Nielsen, N., Roos, G. et al. Cyclin E dependent kinase activity in human breast cancer in relation to cyclin E, p27 and p21 expression and retinoblastoma protein phosphorylation. Oncogene 18, 2557–2566 (1999). https://doi.org/10.1038/sj.onc.1202488

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202488

Keywords

This article is cited by

Search

Advanced search

Quick links